Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;18(12):1039-52.
doi: 10.1111/j.1525-1497.2003.30107.x.

Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians

Stacey Sheridan  1 , Michael Pignone, Cynthia Mulrow
Affiliations

Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians

Stacey Sheridan et al. J Gen Intern Med. 2003 Dec.

Abstract

Purpose: To examine the features of available Framingham-based risk calculation tools and review their accuracy and feasibility in clinical practice.

Data sources: medline, 1966-April 2003, and the google search engine on the Internet. TOOL AND STUDY SELECTION: We included risk calculation tools that used the Framingham risk equations to generate a global coronary heart disease (CHD) risk. To determine tool accuracy, we reviewed all articles that compared the performance of various Framingham-based risk tools to that of the continuous Framingham risk equations. To determine the feasibility of tool use in clinical practice, we reviewed articles on the availability of the risk factor information required for risk calculation, subjective preference for 1 risk calculator over another, or subjective ease of use.

Data extraction: Two reviewers independently reviewed the results of the literature search, all websites, and abstracted all articles for relevant information.

Data synthesis: Multiple CHD risk calculation tools are available, including risk charts and computerized calculators for personal digital assistants, personal computers, and web-based use. Most are easy to use and available without cost. They require information on age, smoking status, blood pressure, total and HDL cholesterol, and the presence or absence of diabetes. Compared to the full Framingham equations, accuracy for identifying patients at increased risk was generally quite high. Data on the feasibility of tool use was limited.

Conclusions: Several easy-to-use tools are available for estimating patients' CHD risk. Use of such tools could facilitate better decision making about interventions for primary prevention of CHD, but further research about their actual effect on clinical practice and patient outcomes is required.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Examples of the information presented in Framingham-based risk calculation tools.
Figure 1
Figure 1
Examples of the information presented in Framingham-based risk calculation tools.
See this image and copyright information in PMC

Comment in

References

    1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–97. - PubMed
    1. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US preventive services task force. Ann Intern Med. 2002;136:161–72. - PubMed
    1. Grundy SM, Bazzarre T, Cleeman J, et al. Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation. 2000;101:E3–E11. - PubMed
    1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–46. - PubMed
    1. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106:388–91. - PubMed

Publication types